Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127800231 | 12780023 | 1 | I | 20160228 | 20160916 | 20160926 | 20160926 | EXP | ES-AGEMED-917523338 | ES-009507513-1609ESP011551 | MERCK | 71.00 | YR | M | Y | 0.00000 | 20160926 | CN | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127800231 | 12780023 | 1 | I | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | 0 | 40 | MG | TABLET | QD | ||||||
| 127800231 | 12780023 | 2 | I | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | 5 MG, QD | 605 | MG | Y | 0 | 5 | MG | FILM-COATED TABLET | QD | |||
| 127800231 | 12780023 | 3 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 80 MG, QD | Y | 70017 | 80 | MG | TABLET | QD | |||||
| 127800231 | 12780023 | 4 | I | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | UNK | Y | 70017 | TABLET | ||||||||
| 127800231 | 12780023 | 5 | I | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, QD | 1210 | MG | Y | 0 | 10 | MG | QD | ||||
| 127800231 | 12780023 | 6 | I | EPLERENONE. | EPLERENONE | 1 | Oral | 50 MG, TID | Y | 0 | 50 | MG | TID | ||||||
| 127800231 | 12780023 | 7 | I | EPLERENONE. | EPLERENONE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 127800231 | 12780023 | 8 | I | TRANGOREX | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, QD | 24200 | MG | Y | 0 | 200 | MG | QD | ||||
| 127800231 | 12780023 | 9 | C | SINTROM | ACENOCOUMAROL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127800231 | 12780023 | 1 | Hypertension |
| 127800231 | 12780023 | 2 | Atrial fibrillation |
| 127800231 | 12780023 | 3 | Hypertension |
| 127800231 | 12780023 | 5 | Hypertension |
| 127800231 | 12780023 | 6 | Hyperaldosteronism |
| 127800231 | 12780023 | 8 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127800231 | 12780023 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127800231 | 12780023 | Acute kidney injury | |
| 127800231 | 12780023 | Atrioventricular block | |
| 127800231 | 12780023 | Bradycardia | |
| 127800231 | 12780023 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127800231 | 12780023 | 1 | 20150514 | 0 | ||
| 127800231 | 12780023 | 2 | 20151031 | 20160229 | 0 | |
| 127800231 | 12780023 | 3 | 20150514 | 2016 | 0 | |
| 127800231 | 12780023 | 4 | 2016 | 0 | ||
| 127800231 | 12780023 | 5 | 20151031 | 20160229 | 0 | |
| 127800231 | 12780023 | 6 | 20150514 | 2016 | 0 | |
| 127800231 | 12780023 | 7 | 2016 | 0 | ||
| 127800231 | 12780023 | 8 | 20151031 | 20160229 | 0 | |
| 127800231 | 12780023 | 9 | 19950501 | 0 |